NYSE grants PACS Group additional trading period until Nov 19, 2025 to file delinquent reports

PACS Group, Inc.

NYSE extended PACS's trading window to Nov 19, 2025, subject to ongoing monitoring, to regain filing compliance.
Company has not filed Q3 2024, annual 2024, Q1 2025, or Q2 2025 reports due to independent audit committee investigation.
Prior financial statements for Q1 and Q2 2024 should no longer be relied upon; restatement is underway.
Company intends to complete restatement and file all delinquent reports within the extension period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.